Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification
Journal of Applied Genetics · 2024
DOI: 10.1007/s13353-024-00840-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Genetics, 2024. Verfasst von Shengting Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical Center, Xi'an Peihua University, Xi'an, 710125, Shaanxi, China. stwang@peihua.edu.cn. Hauptthemen laut MEDLINE: Trastuzumab, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, RNA, Circular. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Medical Center, Xi'an Peihua University, Xi'an, 710125, Shaanxi, China. stwang@peihua.edu.cn.
- Clinical Medical Center, Xi'an Peihua University, Xi'an, 710125, Shaanxi, China.
- Department of Stomatology Technology, Xi'an Peihua University, Xi'an, 710125, Shaanxi, China.
Zitieren
APA
Wang, S., Li, Q., Wang, Y., Li, X., Feng, X., Wei, Y., Wang, J., & Zhou, X. (2024). Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification. Journal of Applied Genetics. https://doi.org/10.1007/s13353-024-00840-9
Vancouver
Wang S, Li Q, Wang Y, Li X, Feng X, Wei Y, et al. Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification. Journal of Applied Genetics. 2024. doi:10.1007/s13353-024-00840-9
BibTeX
@article{Wang2024,
author = {Wang, Shengting and Li, Qian and Wang, Yufang and Li, Xiaoming and Feng, Xinghua and Wei, Yuxuan and Wang, Jiaman and Zhou, Xin},
title = {Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification},
journal = {Journal of Applied Genetics},
year = {2024},
doi = {10.1007/s13353-024-00840-9}
}
EUVIMED